Pharmacoinvasive Strategy in Acute STEMI

  • Isman Firdaus Department of Cardiology and Vascular Medicine, Faculty of Medi-cine, University of Indonesia, and National Cardiovascular Center Harapan Kita, Jakarta
DOI: https://doi.org/10.30701/ijc.v32i4.88

Abstract

Recently, primary percutaneous coronary intervention (PCI) is the best option for reperfusion in STEMI patients, in clinical trials has lower rates of reinfarction, stroke and mortality than fibrinolytic therapy. Because of system delays in routine practice, prehospital administration of fibrinolytic therapy may lead to similar clinical outcomes, especially in those patients who present in early onset after symptom. Assessment of failed reperfu-sion for rescue PCI and invasive strategy after fibrinolitic therapy leading similar outcome with primary PCI. This review focuses on the timing of, and indications for, an invasive strategy after fibrinolytic therapy, including that for failed pharmacological reperfusion.

Downloads

Download data is not yet available.

References

Data Riset Kesehatan Dasar (RISKESDAS) di Indonesia. In: Kesehatan K, ed.; 2007.

Amit Kumar C, Cannon, . Acute Coronary Syndromes: Diagnosis and Management. Mayo Clin Proc 2009;84 (11).

French JK, Andrews J, Manda SO, Stewart RA, McTigue JJ, White HD. Early ST­segment recovery, infarct artery blood flow, and long­term outcome after acute myocardial infarction. Am Heart J 2002;143:265­71.

Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13­20.

Tofield A. Pharmaco­invasive vs. facilitated percutaneous coronary intervention strategies for ST­segment­elevation acute myocardial infarction patients in the new ESC Guidelines. Eur Heart J 2009;30:2817.

Edmond JJ, Juergens CP, French JK. The pharmaco­invasive approach to STEMI: when should fibrinolytic­treated patients go to the “cath lab”? Postgrad Med J 2009;85:331­4.

Edmond JJ, Juergens CP, French JK. The pharmaco­invasive approach to STEMI: when should fibrinolytic­treated patients go to the “cath lab”? Heart 2009;95:358­61.

Surya Dharma, Irmalita, Daniel Tobing, Dafsah A Juzar, Isman Firdaus. ACS Registry In: Kita NCCH, ed.; 2009.

Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631­8.

Danchin N, Blanchard D, Steg PG, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1­year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004;110:1909­15.

Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825­9.

Primary versus tenecteplase­facilitated percutaneous coronary intervention in patients with ST­segment elevation acute myocardial infarction (ASSENT­4 PCI): randomised trial. Lancet 2006;367:569­78.

Ting HH, Krumholz HM, Bradley EH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 2008;118:1066­79.

Ellis SG, Da Silva ER, Spaulding CM, Nobuyoshi M, Weiner B, Talley JD. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000;139:1046­53.

Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST­segment myocardial infarction: a meta­analysis of randomized trials. J Am Coll Cardiol 2007;49:422­30.

Sutton AG, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST­segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol 2004;44:287­96.

Gershlick AH, Stephens­Lloyd A, Hughes S, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005;353:2758­68.

Ganz W, Ninomiya K, Hashida J, et al. Intracoronary thrombolysis in acute myocardial infarction: experimental background and clinical experience. Am Heart J 1981; 102:1145­9.

Califf RM, O’Neil W, Stack RS, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988;108:658­62.

French JK, Feldman HA, Assmann SF, et al. Influence of thrombolytic therapy, with or without intra­aortic balloon counterpulsation, on 12­month survival in the SHOCK trial. Am Heart J 2003;146:804­10.

Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804­47.

Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST­elevation myocardial infarction: the WEST (Which Early ST­elevation myocardial infarction Therapy) study. Eur Heart J 2006;27:1530­8.

Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST­elevation myocardial infarction. Circulation 2007;116:721­8.
Views & Downloads
Abstract views: 2682   
PDF (Bahasa Indonesia) downloads: 4849   
How to Cite
Firdaus, I. (1). Pharmacoinvasive Strategy in Acute STEMI. Indonesian Journal of Cardiology, 32(4), 266-71. https://doi.org/10.30701/ijc.v32i4.88
Issue
Vol. 32, No. 4 Oktober - Desember 2011
Section
Review Article

Authors who publish with this journal agree to the following terms:

    • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).